bioRxivCell Biology
Genome-Scale CRISPR Screening Identifies Novel Human Pluripotent Gene Networks
R. J. Ihry, M. R. Salick, D. Ho, M. Sondey, S. Kommineni, S. Paula, J. Raymond, E. Frias, K. A. Worringer, C. Russ, J. Reece-Hoyes, B. Altshuler, R. Randhawa, Z. Yang, G. McAllister, G. R. Hoffman, R. Dolmetsch, A. Kaykas
Abstract
Human pluripotent stem cells (hPSCs) generate a wide variety of disease-relevant cells that can be used to improve the translation of preclinical research. Despite the potential of hPSCs, their use for genetic screening has been limited because of technical challenges. We developed a renewable Cas9/sgRNA-hPSC library where loss-of-function mutations can be induced at will. Our inducible-mutant hPSC library can be used for an unlimited number of genome-wide screens. We screened for novel genes involved in 3 of the fundamental properties of hPSCs: Their ability to self-renew/survive, their capacity to differentiate into somatic cells, and their inability to survive as single-cell clones. We identified a plethora of novel genes with unidentified roles in hPSCs. These results are available as a resource for the community to increase the understanding of both human development and genetics. In the future, our stem cell library approach will be a powerful tool to identify disease-modifying genes.\n\nVISUAL ABSTRACT\n\nO_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=176 SRC=\"FIGDIR/small/323436_ufig1.gif\" ALT=\"Figure 1\">\nView larger version (48K):\norg.highwire.dtl.DTLVardef@5101e4org.highwire.dtl.DTLVardef@5321f2org.highwire.dtl.DTLVardef@1d9c94corg.highwire.dtl.DTLVardef@12ebd53_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- research focus: gene regulatory network inference
- research focus: cell type annotation
- research focus: differential expression
- research focus: variant calling
- approach: genetic perturbation / CRISPR
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- P53 toxicity is a hurdle to CRISPR/CAS9 screening and engineering in human pluripotent stem cells
Robert J. Ihry, Kathleen A. Worringer, … Ajamete Kaykas·Nature MedicinePeer-reviewed·Jun 8, 2018
- Parallel genome-scale CRISPR-Cas9 screens uncouple human pluripotent stem cell identity versus fitness
Bess P. Rosen, Qing V. Li, … Danwei Huangfu·Nature CommunicationsPeer-reviewed·Oct 17, 2024
- CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons
R. Tian, M. A. Gachechiladze, … M. Kampmann·bioRxiv·Jul 3, 2019
- Optimised whole-genome CRISPR interference screens identify ARID1A-dependent growth regulators in human induced pluripotent stem cells
S. Usluer, P. Hallast, … L. Parts·bioRxiv·Oct 3, 2022
- Multiplexed and Inducible Gene Modulation in Human Pluripotent Stem Cells by CRISPR Interference and Activation
Dane Z. Hazelbaker, Amanda Beccard, … Lindy E. Barrett·Scientific ReportsPeer-reviewed·Jan 20, 2020
- Recurrent genetic abnormalities in human pluripotent stem cells: definition and routine detection in culture supernatant by targeted droplet digital PCR
S. Assou, N. Girault, … J. De Vos·Stem Cell ReportsPeer-reviewed·Jan 1, 2020